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Abstract 
Statistical analyses for a nonorthogona.l four row by 17 column design 
involving four treatments are presented. Analyses of variance, tranforma-
tion of data, and confidence interval estimation are presented for several 
responses. A study of residuals i~ made resulting in the eliminating of 
responses from several patients and a re-analysis of the remaining data. 
A possible misconception in combining statistical analyses for sets of 
nonorthogonal data is discussed. 
Introduction 
MJ.ltiple measurements were collected on a set of 17 patients. The.trea.tment 
design involved a mixture of drugs; the experiment design was a nonortho·gonal patient 
(row) by visit (column) design with four different treatments for patients suffering 
asthma attacks. For the experiment the asthma attacks were induced by use of a 
mediator which was either histamine or methacholine and several responses were 
measured both 'before and after the mediator was administered. Several statistical 
analyses are presented. An outline of the paper follows: 
The Treatment Design 
The Experimental. Plan or the Experiment Design 
Statistical Response Models 
A Statistical Analysis of the Data on Concentration for Visits 3 and 5 
with Histamine 
*In the Mimeo Series of the Biometrics Unit, Cornell University, 337 Warren Hall, 
Ithaca, N. Y. •. 14853. 
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A Statistical Analysis of the Data on Concentration for Visits 4 and 6 
1-1i th Methacholine 
A Combined Statistical Analysis of the Data on Concentration for Visits 
3, 4, 5, and 6 
A Statistical Analysis for the Data on Forced Expiratory Volume (FEV) 
for Visits 3 and 5 
A Statistical Analysis for the Data on Forced Expiratory Volume (FEV) 
for Visits 4 and 6 - ANOVA taoles 
A Statistical Analysis for FEV1 VC, MMEF, SP, DP, and Pulse Data from 
Visits 3, 4, 5, and 6 
Transformations and Additivity Studies for Concentration Data for Visits 
1, 3, and 5 
An Artificial Example - A Useful Device and a Possible Misconception in 
Analysis of Nonorthogonal Data 
The Treatment Design 
The treatment design consisted ot the following four treatments for each of 
two mediators, histamine and methacholine, 
P.la.ce'bo - denoted 'by P throughout the following discussion 
Scholl's 1000-BR - denoted by S throughout the following discussion 
Isoproterenol - denoted oy I throughout the following discussion 
Combination of Isoproterenol and Scholl's 1000-BR - denoted oy C = S +I • 
One could consider this design to oe a ~-factorial as follows: 
Histamine Methacholine 
Level level of S Level level of S 
of I 0 1 of I 0 1 
0 0 
l 1 
't-There 0 means the drug wa.s a·osent and 1 means the drug was :present in the treatment. 
One fUrther aspect of the treatment design is the fact that the treatments 
were applied in a sequence over the six visits of each of the 17 patients. Sequence 
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l, for example, was PPSIPC and 1qas ~iven to patients 8o1 and 813. There were eight 
sequences of treatments and these are denoted Oy s1, s2, · • ·, s8 in the last column 
of Table 1. These sequences are useful in assessing carry-over effects of one treat-
ment on the next visit of a patient. 
Some sequences do not have any letters in common from visit three through 
visit six; two such sequences are: 
PPSIPC = sequence 1 
PPISCP = sequence 6 
As indicated in Table 2, there are six such pairs of sequences. The ten sequences 
having three letters different are giveniin column two of Ta'b.le 2. Likewise, the 
twelve pairs of sequences.having only two letters in common are given in the last 
column of Ta.ble 2. 
. . 
Since patients are orthogonal to treatments and to visits, the sum of squares 
among patients may be partitioned as follows, either for all six visits in Table 1 
or only the last four visits: 










An F-test of the among-sequences mean square and the within-sequence mean square 
may be made as indicated in the above ta"ble. 
An ana.lysis.of the above type was not made because no interest in the sequences 
was indicated by the experimenter. 
-4-
Table 1. Experimental plan of drug administration 
to 17 patients on 6 successive visits. 
Treatment for Visit Number Sequence 
Patient and Mediator* of 
num:oer 1-H 2-M 3-H 4-M 5-H 6-M treatment 
801 p p s I p c BJ. 
8o2 p p s I c p Sa 
8o3 p p I s p c Sa 
8o4 p p p s I c 84 
8o5 p p I p s c Ss 
8o6 p p I s c p sa 
8o7 p p s p I c ~ 8o8 p p p I s c Sa 
8o9 p p I s p c Sa 810 p p p s I c s4 
811 p p I s c p sa 
812 p p s I c p Sa 813 p p s I p c 1\ 814 p p p I s c sa 
815 p p s p I c s7 
816 p p I p s c Bs 8.17 p p p s I c 84 
. 
*Treatments are P = place·bo, S =Scholl's 1000-BR, I = Isopro .. 
terenol, and C = S +I in combination. The two mediators are 
histamine (H) and methacholine (M). Patient 817 is number 
819 in the experiment. 
Ta"ble 2. Relationships among sequences of treatments 
in visits 3 to 6. 
Pairs of sequences differing by 
Four letters Three letters Two letters 
~ and s6 t\ and s4r s,_ and Sa 
Sa and Sa t\ and s6 ~ and s3 
Sa and s4r sa and s7 ~ and s., 
Sa and s6 Sq and s8 sl and s8 
ss and s7 sa and s7 Sa and s6 
se and Sa Sa and s8 Sa and s4 
s4r and as sa and Bs 
s4r and Be sa and s8 
Ss and s6 s4 and s., 
a., and Sa 84 and Be 
Ss and s7 
Ss and Sa 
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The Ex,perimental'Plan or the Experiment Design 
The experimental plan (or the experiment design) is given in Table 1. There 
\•Tere two mediators, histamine (H) and methacholine (M). The histamine mediator 'YTas 
given on visits 1, 3, and 5 of the 6 visits of these 17 patients to the laooratory 
or medical center. Methacholine ~ras given to the patients on visits 2, 4, and 6. 
Thus, the experiment design indicates that three analyses of the data on each char-
acteristic are desired. Also, the doctor kne't'T the identity of the treatments on 
visits 1 and 2, out the patient did not. This part i-las a singly blind study. Since 
neither the doctor nor the patient knew the identity of the treatment on visits 3, 
4, 5, and 6, the study was doubly olind for these visits. The three analyses 
suggested to us are: 
( i) An analysis of the data from visits 3 and 5 for the histamine 
mediator. 
(ii) An analysis of the data from visits 4 and 6 for the methacholine 
mediator. 
(iii) An analysis of the data from all four visits combined. 
It was not possi"b.le to use an appropriate randomization since treatment C could 
not be administered until both treatments I and S were tried on the patient. Hence, 
in no case can C appear anywhere ·out on visits 5 and 6. It is assumed that this 
restriction on the randomization does not affect the inferences that can be made 
from'lhese data. Several data analytic approaches will ·oe used to check for con-
founding 'betw·een visits 5 and 6 and the results for treatment C. 
Statistical Response Models 
For the three analyses suggested in the previous section, we shall assume the 
following linear model for the observations: 
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Yhij = the response ootained from the jth visit .. and ith 
treatment for patient h 
where ~ is an effect common to all ooservations, ph is an effect due to the hp~ 
patient, ti is the effect of the i~h treatment, vj is an effect due to the jth 
visit, ehij is an error component due to patient h, treatment i, and visit j, the 
eh. . are considered to have mean zero and variance a2 and to oe normally and inde-l.J e 
pendently distribUted. For the patients of this experiment the expected value of 
Yhij is ~ + ph + ti + vj • If the patients represent a random sample of patients 
from some specified population of patients, then the expected value of Yhij is 
~ + ti + vj and the ph are considered to oe independently and identically distrio-
uted 'Y1i th mean zero and variance 0'~ • Also, h = 1 , 2, • • ·, 17; ti = P, S, I, C; and 
j = 1, 2, 3, 4, 5, 6 . 
Another response equation could oe 
Yfgh. = ~ + ph + t. + m + wf + tm. + ef h. , l. l. g g l.g g l 
where mg, g = H or M, is an effect due to the gth mediator, wfg is an effect due to 
the f~ visit using mediator g, and tm. i·s an interaction effect of the i th treat-J.g 
ment in combination 'qith the gth mediator, and the remaining effects are as described 
a·oove. One could also add interaction terms· for treatments and patients and for 
patients and visits. 
One could also add a one-period residual effect for the ith treatment. It is 
not ·oelieved that a treatment could have an effect oeyond the visit on \'Thich it is 
administered. Since not all interaction and/or residual effects can oe estimated, 
one must oe cautious aoout adding additional terms to the model. Perhaps an indi-
--
vidual degree of freedom Tukey-type of interaction could oe introduced into the mode 1 
for patient oy treatment and patient oy mediator types of interaction. Whether or ~ 
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not this type o~ model ~dll ne sufficient to account for the interactions ~~ll need 
to be investigated. 
Also, one grou~ of patients may follow one model and a different group may 
i\ 
follow a different model. Some of these possiQ~.lities will oe investigated. 
A Statistical Analysi~ of the Data on Concentration for Visits 
3 and 5 with Histamine 
The data for concentration, at which the mediator was stopped, are presented 
in Table 3 for visits 1, 3, and 5 using the histamine mediator. The data from 
visit 1 is considered to ne the base"line value for a :patient. The subtraction of 
this value from the data. from visits 3 and 5 is considered to oe a oaseline correc-
tion. It should be noted that the su'otraction of the baseline value does NOTHING 
out change the size of estimated patient effects and sums of squares involving 
patient effects. The estimated treatment and visit effects using the first statis-
tical model in the preceding section are identical whether the baseline values are 
suotracted or not. Hence, it is recommended that these additional computations oe 
omitted. It should also ·oe noted that the su·btraction of the baseline value is a 
covariance analysis using one as the value of the regression coefficient. The above 
statements hold for any value of the regression coefficient. Computations are 
carried out, h~vever, (see Tables 4a and 5) to demonstrate this point. 
Since the experiment design is highly nonorthogonal, it was necessary to set up 
the 24 = 1 + 17 + 2 + 4 normal equations for the mean> 17 patients, 2 visits, and 4 
treatments and to solve this set of equations for solutions of parameters. The 
solutions :for the treatment and visit effects are given a.t the bottom of Table 4, 
using the statistical model in the first part of the preceding section. 
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Table 3. Concentration at which the histamine mediator was stopped. 
Patient Visits Visits 
Number 1 3 5 Totu 3+5 3 -1 5-1 Total 
Sol 0.25 0.50 5. 0<:' 5. 75 5.50 0.25 4.75* 5.00 
8o2 2.50 5.00 10.00 17.50 15.00 2.50 7.50 10.00 
8o3 o.o6 o.o6 1.00 1.12 l.o6 0.00 0.94 0.94 
8o4 2.50 2.50 1.00 6.00 3.50 0.00 -1.50 -1.50 
8o5 0.25 0.25 0.50 1.00 o. 75 0.00 0.25 0.25 
8o6 0.25 0.12 10.00 10.37 10.12 -0.13 9·75 9.62 
&Jr o.o6 1.00 0.25 l. 31 1.25 0.94 0.19 1.13 
8o8 0.12 0.50 1.00 1.62 1.50 0.38 0.88 1.26 
809 0.50 0.25 1.00 1.75 1.25 -0.25 o. 50 0.25 
810 2.50 10.00* 5.00 17.50 15.00 7- 5cY 2. 50 10.00 
811 0.50 0.50 5.00 6.00 5.50 0.00 4.50 4.50 
812 0.12 0.25 0.50 0.87 0.75 0.13 0.38 0.51 
813 o.o6 0.12 0.12 0.30 0.24 o.o6 o.o6 0.12 
814 0.50 5.00* 1.00 6.50 6.00 4. 50* o. 50 5.00 
815 o.o6 2.50 0.25 2.81 2. 75 2.44 0.19 2.63 
816 0.50 2.50 2.50 5.50 5.00 2.00 2.00 4.00 
817 0.12 o.o6 o.o6 0.24 0.12 -O.o6 -o.o6 -0.12 
Total 10.85 31.11 44.18 86.14 75.29 20.26 ! 33·33 53-59 
Total for visits 3 and 5 (number) Tota.ls 
p = 25.18(9), !=10.24(11), p = 18. 57(9), I= 2. 94(11) 
c = 25. 50(4 ), s = 14. 37(10) C=22.13(4), s = 9· 95(10) 
* Large differences ~dth same treatment P • 
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Table 4. Analysis ~6f variance; ·£r:eatmeP.t and Ylsit ·'e'ftects and treatment 
covariance matrix '-for Vi~its 3 a.rtd. 5, f~r "concen-cratidif 'data.. 
Degrees of SUm of Mean 
Source of variation freedom squares sr_a~_:. F-ratio 
Total 34 457.6165 
Correction for mean 1 166.7231 
Patients (ignoring :treatments) 16 183.9882 11.4993 
Among sequences 7 
Within sequences 9 
Visits (ignoring treatments) 1 5.0243 5.0243 
Patients x visits (ignoring 
treatments) 16 101.8809 6.3676 
Treatments (eliminating 
patients and visits) 3 61.8366 20.6122 6.69 
Remainder 13 4o.o443 3.0803 




I = -2.21 • 
"' .157407 . 024632 • 046163 -.o63884 s = -1.26 
~ 
p = -0.03 0 .144737 .013158 -.092105 
A 
c = 3.51 0 -. 008373 .168660 -.18o622 
Visit effects 0 -.003589 -. 070574 .494019 
" 
Ya = 0.17 
A 




Table 5. Analysis of variance, treatment and visit effects, and 
covarianee matrices for visit 1 su·otraeted from 3 and 5. 
Degrees or Sum of Mean 
Source of variation :treedom s~ares sg.uare F-ratio 
Total 34 302.9669 
Correeti&n for mean 1 84.4673 
Patients (ignoring treatments) 16 111.5944 6.9746 
Am.ong sequences "7 
Within sequences 9 
Visits {ignoring treatments) 1 5.0243 
Patients x visits (ignoring 
treatments) 16 101.8809 6.3676 
Treatments (eliminating 
patients and visits) 3 61.8366 20.6122 6.69 
Remainder 13 40. o443 3.0803 




"' s = 
Same as in Table 4 "' p = 






After eliminating the effect of nonorthogonality of visit and patient effects 
. ( 1 ' , ' ,.t 
. l'... 
from the treatment effects, we note that there are highly significant differences 
.0 .~--
among treatments, that is F = 6.6gr, and the ta·oulated value of F at the one percent 
point is 5.74. Now looking at the treatment effects, we note that treatment C gives 
the highest concentration and that treatment I gives the lowest. The variance of 
this contrast would be 
[ .157407 + • 494019 - 0 - (-. o63884) ]3. 0803 = 2. 2034 
At-test ,.,ould be t = [3.51- (-2.21)]//2.203 = 3.85, -vrhich is greater than 
t.Ol,l3df = 3.01 . Likewise, the 95% comparisonwise confidence interval is com-
puted as 
3. 51 - ( -2. 21) ± 2 .16<V 2. 2634 = 5. 72 ± 3. 2o6 
Similar values for all possible differences among the four treatment effects are 
given below. 
Differences and 95% comparison,r.ise confidence intervals 
for treatment means (or . effects) adjusted 
for visit and patient effects 
Treatment 
Treatment c p ·S 
I 5.72 ± 3.2o6** 2.18 :I: 2. oo6* o. 95 ± 1.9g-( 
s 4.77 ± 3.24~ 1.23 ± 2.lo6 
p 3· 54 ± 3.624 ? 
* Difference significant at 5% level. 
** Difference significant at 1% level. 
? Difference almost significant at (t = 2.11 vs. t. 06913 = 2.16) 
at the 5% level. 
The significance test used in e..ll cases·,a.bove wa.s the Student t-test. 
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The error rate used &cove was a comparisonwise error rate. Alternatively, one 
could use a ~r experiment oy using ta/m,df' where m = numoer of comparisons to ·oe 
made and df = degrees of freedom in the error mean square, instead of t 0 df or an 
' 
experimentwise error rate ·oy using studentized-range va..lues a_ df' where v =number u,v, 
of treatments, in place of /2t0, df • Of course, there are several other error rate 
bases that could be utilized (e.g., see Chapter II of Experiment~ Design - Theory 
and Application, Macmillan Co., N.Y., 1955, by W. T. Federer). 
A 
It is surprising that P, the estimated treatment effect for the P treatment, 
A A 
exceeds the estimated effects, I and S, for the I and S treatments. One might sus-
pect some sort of interaction or one might suspect some unusually large values, out-
liers, for the P treatment, or some unusually small outliers for the I and S treat-
ments. First, we shall investigate whether or not one might suspect that the error 
mean square, 3.0803, is unusually large for data of this nature. To do this we look 
at the data from patients during visits 1 and 2. Now visits 1 and 2 should allow 
one to estimate what the within- and among-patient variation is for concentration. 
Before doing this 1 one should note that the variation -in H and in M should be diff-
erent simply because the range of concentrations for H is zero to 10 while that for 
M is zero to 25. Therefore, in T&ole 6 the visit 2 concentrations are multiplied 
by .4 = 10/25 in an attempt to equalize the variances. The among-patient variance 
for visit l (H) is 0.8169, while that for .4 (visit 2 (M)) is 0.2382 (see Table 6). 
The patient oy visit variance here "1.-Tas 0.2000 (see Taole 6). This appeared to 
overcorrect. Therefore, the uncorrected values for visit 2 were used in the Taole 
7 calculations. The visit 2 among-patient variance is 1.82 times larger than the 
visit 1 variance. The patient ·oy visit interaction is 0.3316. None of the variances 
descrioed here are as large as the residual variance for visits 3 and 5, 3.08o3, in 
Ta·oles 4 and 5. 'nlis varianc.e is. over 9 times larger than the error variance, 0. 3316, 
that one might consider appropriate. A good share of this large remainder variance ~ 
e 
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Table 6. Analysis of concentrations on visits 1 and 2 
! ,. ;using .4.(conc;:entration~ of visit 2). · 
Patient Visit 
number .1 2( .4) Sum 
801 0.25 0.12 0.37 
8o2 2.50 0.25 2.75 
8o3 o.o6 O~.ob . -0.12 
8o4 2~50. 1~00 3(50 
8o5 . 0~25 1 : 0.12 'o~ 37 
8o5 0.25 : -0.25 0.50 
&rr o.o6 - q.o6 0.12 
808 0.12; 0.12 > 0.24 
809 0.50 0 •. 50 1.00 
810 2.50 ') '·'- 4.50 . 2,.00 
811 o. 50 0."12 0.62 
812 0.12 o.o6. 0.18 
813 o.o6 o;:25 0.31 
814 0.50 0.25 0.}5 
815 o.o6 . '0.25 o. 31 
816 0.50 0.12 0.62 
817 0.12 o.o6 0.18 
Total 10.85 5.59 16.44 
-
Source of variation 
Total 
































Sum of squares 
' Visit, !1 
Visit .. 2 :X .4 
19.9951 (17df) 
5.6489 (17df) 
Var~~nce among pati~nts 
visit ·1 o. 8169 
Visit 2 X .4 0.2382 
9.81g~ - 3 43 0.23 2 - • 
;F. 05 ( 16, 16 ) = 2. 3 3 
Sum of Mean 
sg,nares sg.uare F-ratio 
25.6440 
7. 9492 
., . ' 
13.6813 0.8551 4.28 










Table 7. Analysis of' concentrations on visits 1 and 2. 
Patient Visit 
number 1 2 SUm 
8o1 0.25 0.31 o. 56 
8o2 2.50 0.62 3.12 
8o3 o.o6 0.15 0.21 
8o4 2.50 2.50 5.00 
8o5 0.25 0.31 0.56 
8o6 0.25 0.62 o.&r 
&:17 o.o6 0.15 0.21 
8o8 0.12 0.31 0.43 
8o9 0.50 1.25 1.75 
810 2.50 5.00 7.50 
811 0.50 0.31 0.81 
812 0.12 0.15 0.27 
813 o.o6 0.62 0.68 
814 0.50 0.62 1.12 
815 o.o6 0.62 0.68 
816 0.50 0.31 0.81 
817 0.12 0.15 0.27 
Total 10.85 .14. 00 24.85 
Source of variation 
Total 
Correction for mean 
Patients 
Visits 
Patients x visits 







































o. 8169 = .1. 82 
F. 05(16,16) = 2.33 
SUm of Mean 
s9:!:a.res S9:!:are F-ra.tio 
55.3001 
18.1624 
3L5o82 1.9693 5.94 
0.3233 0.3233 0.97 






appears to be due to three discrepant values. 'lbese are (see asterisk in 'I'able 
3): . ./' -~~ 
Patient 810 
-
visit 3, treatment :P 
. -
-. : ·. ~ "''!-




visit 5, treatment P 
Omission of the at>ove three data points and solution of the resulting 24 normal 
equations results in the following solutions, where J.l.~~h solutions are obtained 
A A 
instead of J.1. and ph: 
A 
J.1. +p1 = LOOO 
A . 
J.l +p2 = 5.909 
A 
J.1. +p3 = 2.121 
A 
J.1. +p4 = 3-341 
A 
J.1. +p5 = 1. 705 
A 
J.1. +p6 = 4. 1CJ7 
A 
J.1. +17. = 1.955 
~P8 = 1.613 
J.I.~P9 = 2.216 
Treatment effects 
A 
p = -1.124 
"' I = -2.057 
"' s = -0.603 
"' c = 3.784 
Visit effects 
A 7.160 J.l. +plO = 
A 1.887 J.1. +pll = 
A 
J.1. +pl2 = -L216 
.A.. 0.983 J.1. +pl3 = 
A "·. 
J.1.+pl4 = L7o6 
/':'-. 2.705 J.1. +pl5 = 
I.J.-1),16 = 3-~30 
A 1.651 J.1.+pl7 = 
Variance-covariance matrix/2.0599 
38o' 110 65 -1.12 
0 150 -15 -132 
0 30 225 ·72 
0 90 105 696 
From the a·oove solutions for effects, we compute the residuals as: 
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These are given, in· Table 8. The •'largest :re!IIL\ining residu&ls are now those for 
patients 806 and 812. The data point for patient 8o6, visit 5, a~pears to be too 
high while that for patient 816, visit 5, appears to be too low. These residuals 
of the order ±2 are more than three times larger th&n any of the remaining residu-
als. An analysis could oe, but was not, performed on the data lrlth the a·bove five 
'
1discrepant•• va.lues removed. One should study characteristics of patients such 
as these five to determine the sources of their erratic behavior relative to the 
other patients in this experiment. It is possible that several types of patient 
response to concentration of a mediator are possi.ble. This may mean that different 
treatments would ·oe prescri·oed for different types of asthma sufferers. 
An analysis of variance and 95% comparisonwise confidence intervals are pre-
sented in Table 9· The rem&inder mean square from Taoles 4. and 5 was 3. 0803, while 
the one in Taole 9 is 2. 0599. This is a 1/3 reduction ·out it is still a·oout six 
times larger than the patient ·oy visit mean square 0.3316 in Table 7. If one were 
to eliminate the four largest residuals, the resulting mean square would be 
[20.5988 - (-2.123)2 - 2.1222 - 1.9662 - (-1.965)2 ]/8 = 0.4828, which is in the 
same general area. as 0.3316 • It appears that using a mean square of 3.0803 is too 
large for com:paring treatment effects as in Tables 4 and 5. It is not clear what 
should oe an appropriate error for visits 3 and 5 data~ Note that the data from 
visits 1 and 2 were singly blind data and hence would proba'oly ·oe expected to oe 
less variable than data from douoly olind tests. Also, any significance statements 
for the results in Table 4 are pro·bably on the conservative side with respect to 
Type I errors. Despite this, the only exception in significance statements are 
that treatment C is now significantly higher than treatment P at the 1% level, 
whereas it did not reach the 5% level previously, and treatment P is now not sig-
nificantly higher than treatment I. The estimated treatment effects for both cases 
are listed ·belm'l for comparison: 
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Ta.ol-e 8. · Residuals for conce'ntration data with histamine ·mediator 
after onii tting dlrtia. for three discrepant values 
(dashes in the table). 
Visit 




8o2 - .409 + .410 +.001 
8o3 - .1Cf7 + .to6 -.001 
804 + .180 - .181 -.001 
8o5 + .499 - .499 .000 
8o6 -2 .. 123 2.122 -.001 
8crr - .455 + .455 +.000 
8o8 
-
.Q92 + .093 +.001 
809 - ·.012 + .011 -.001 
810 
- 0 0 
811 + .567 - . 568 -.001 
812 1.g66 -1.965 +. CX)l 





815 + .295 - .295 .ooo 
816 + .624 - .624 .000 
817 - . 570 + . 569 -.001 
Sum* .000 - .002 -.002 
* Zero within rounding. 
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Ta.ble 9. Analysis ot variance tor visits 3 and 5 omitting the three 
discrepant values together with the ditrerenees and confidence 
intervals for estimated treatment effects. 
Source of variation d. f. Sum of S!E&res Mean s9.ue.re F-value F .01 
Total 31 307.6165 
Correction of mean 1 98.6124 
Patients (ignoring visits 
and treatments) 16 132.7239 
Visits (eliminating patients 
but ignoring treatments) 1 11.0252 
Treatments (eliminating ·both 
patients and visits) 3 44.6562 14.8854 7.23 6.55 
Remainder 10 20.5988 2.0599 
The differences and 95% comparison~dse confidence intervals for the four treatments 





5. 84 :t 2. 822* 
4 . 91 :f: 3. 264* 
s 4. 39 ± 2. 822* 
Treatment 
s 
1. 45 :f: 2. o68 
0.52 ± 2.536 
* Significant at the 5i level. 
p 
0. 94 :f: 1. 941 
-19-
All data Without ~ discreEant values 




s -1.26 -0.63 
,.... 
-2.o6 I -2.21 
Treatment I retains bottom position and C reta~ns the t~ position but the ranks of 
P and S interchange, depending upon w?ether the three discrepant values are retained 
or omitted. 
Further study of these data wili oe made later in the report when the effect 
of transformation of the data is investi'gated. 
A Statistical Ana1ysis of the Data on Concentration for 
Visits 4 and;6 with Methacholine 
The data for visits 2, 4, and 6 using the mediator methacholine to induce an 
asthma attack, are presented in Table 10. An analysis of variance taole and the 
estimated effects for treatments and visits 4 and 6 are presented in Table 11. The 
-.,~. 
remainder variance here,. 26.3203, is much larger than the variation among patients 
for visit 2, that is 1.4860. Hence, considerable patient ·by treatment interaction 
and/or control by the doctor in visit 2 due to the fact that the studY was singly 
·olind and the doctor may not have allowed any patient to take the higher concentra-
tion~ must have 'been present in this experiment. Also, note that the residual .mean 
square 26.3203 for methacholine was 8. 5 times larger than the residual mean ·-square 
3.o8o3 using the mediator histamine. As pointed out before the possible range of 
values was in the ratio of 10/25 = 0.4, and that (0.4)2 (26.3203) = 4.2 which is not 
much different from 3.o8o3. This result differs from that in Ta'ble 6, but there it 
-20-






















(Concentration data) . Sum 
2 4 6 
0.31 1.25 25.00 
0.62 o. 31 0.31 
0.15 1.2? 1Q.OO 
2.50 25.00 25.00 
0.31 0.62 5.00 
0.62 25.00 1.25 
0.15 0.~5. .5.00 
0.31 0.62 1.25 
1.25 0.62 2.50 
5.00 25.00 25.00 
0.31 l.f?5 0 • .15 
0.15 0.15 0.62 
0.62 2.50 10.00 
0.62 2.50 5.00 
0.62 0.31 5.00 
0.31 0.31 1.25 
0.15 1.25 0.62 
14.00 88.09 122.95 
Treatment 
y c 
• p. 3.72 ( B) 
y 





79.37 ( 7) 











































y = 0.63 ( B) 
• P• 
y 
. C· = lo8.32 (13) 
= 69.39 ( 7) 
4.70 ( 6) 























Table 11. Analyses of variance 1 treatment and visit effects, 
and treatment covariance matrix for visits 4 and 6 
for concentration data in Table 10. 
Degrees of Sum of 
Source of variation freedom s!lua.res Mean square F-ratio 
Total 34 4082.0614 
Correction for mean 1 1309.9377 
Patients 16 2102.8571 131.4286 
Visits 1 35.7418 35.74.18 
Patient X Visit 16 633.5248 39.5953 
Treatment (eliminating 3 291. 36o6 g-(.1202 3-69 
patients x visit) 
Remainder 13 342.1642 26.3203 
Visit (eliminating treatment) 1 Not computed 
Treatment effects 
A ·· Covariance ma trix/26. 3203 
·333333 -.002874 -.270115 -.580460 I = -7.96 A 
s = 0.52 
"' p = -2.03 0 .284483 -.258621 -.534483 
c = 9.47 0 .008621 . 3103)_1-5 .241379 
Visit effects 0 .043.103 .551724 1.206897 
A 
v4 = 3.89 
A 




must ·oe rememoered that the doctor ~ have ruled out higb concentrations, thus 
not allowing the fUll range ot concentrations to be utilized on either visits 1 
or 2. 
In studying the estimated treatment effects a table of differences ·between 
estimated effects as well as the 9'51o comparisonwise confidence intervals is useful. 
SUch a table is presented below: 
Differences between estimated effects (or means) and 95% 






17.43 :1: 16.138"' 
11. 50 :Z: 9· 4301" 
8. 95 ± 15.6o4 
Treatment 
s 
8. 48 :1: 8. 730? 
2.55 :i: 10.186 
p 
5.93 :i:: 10.593 
* Significant at the 5% level; ? Almost significant at the 
5% level. 
From the above we note that treatment C again appears at the top, that is allowing 
the patient to withstand a higher concentration than t:ne :remaining treatments. 
Treatment C is significantly higher than treatments P and I but not S. Treatment 
s is significantly higher than treatment I at about the 6% level but not at the 5%. 
Treatment I appears at the bottom again. It appears to hinder the patients from 
withstanding as high a concentration level as they would with no treatment, i.e. 
P. However, this could arise from sampling variation. 
The responses to treatments P and I in Table 10 appear to vary relatively 
little compared to the responses to treatments S and C. This could mean that for 
asthma attacks induced by the mediator methacholine, considerably different results 
can be obtained from patient to ~atient tor treatments S and C. This may also be 
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due to the particular patients who happened to receive these treatments in the 4th 
and 6th visit. From a study of responses in both Tables 3 and 10, the following 
five patients appear to respond differently from the remaining 12 patients: 
Visit (concentration and treatment) Possible 
Patient no. 3 4 5 6 nature 
8ol o. 50-s 1.25- I 5.00-P 25.00- c erratic 
8o6 0.12- I 25.00- s 10.00- c 1. 25- p erratic 
810 10.00-P 25.00- s 5.00- I 25.00- c uniform-high 
814 5.00- p 2. 50- I 1.00-S 5. 00- c erratic 
812 0.25- s 0.15- I o. 50- c 0.62- p uniform-low 
There is a possibility of very uniform responding patients as patient 812, and 
possibly 806, and of patients with erratic responses. Both these groups contrib-
ute to large residuals relative to the remaining patients. An in-depth study of 
the characteristics of these three groups may throw some light on the nature of 
this type of response and may indicate differential treatment for the groups. One 
should also study patient 812, i-rho appears to indicate a. slightly increasing concen-
tration ability. Was this psychological? Also, why was patient 810 so tolerant of 
high concentrations? What caused the erratic oehavior of patients 8o1, 810, and 
814? 
A Combined Statistical Ana1ysis of the Data on Concentration 
for Visits 3, 4, 5, and 6 
An analysis of variance for the comoined data of Tables 3 and 11 is: 
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Sources of variation 
Total 
Correction for the overall mean 
Patients 
Visits (ignoring treatment effects) 
Mediator =Visits 3 + 5 versus 4 + 6 
Visits within histamine (3 versus 5) 
Visits within ~thacholine (4 versus 6) 
Patients X visits (ignoring treatment effects) 
Treatments (eliminating visits; ignoring interactions} 
Treatment x mediator (elim. treat., visit and patient) 
Patient x mediator (eliminating all else) 
Patient X visit l'Tith mediator (elim. treat.) 
Within histamine 
Within methacholine 















Note that treatments and visits are orthogonal to patients ·out that patients are not 
orthogonal to the treatment by mediator interaction effects. These latter effects 
are estimable, however, as ~ be noted from the following table of frequency of 
observations in the 2 x 4 table: 
Treatment 
Mediator p I s c Sum 
H 9 11 10 4 34 
M 8 6 7 13 34 
Sum 17 17 17 17 68 
e 
A shortened version of the above analysis of variance is presented in Tao1e 12. e 
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Table 12. Analysis of vari~nce, treatment and visit effects, 
and covariance me:tricb'$ for concentration data from 
visits 3, 4, 5, and 6. 
Source of variation 
Total 
Correction for mean 
Patients 
Visits (ignoring treatments) 
Treatments (eliminating visits; 
ignoring interactions) 
Treatments x mediator plus patient 
x .mediator (eliminating visit, 






I = -3.27 
A 
s = 0.99 
p = -2.46 
c = 4.73 
Visit effects 
.... 
V3 = -1.05 
.... 
V4 = 1.09 
A 
v6 = -0.44 
A 
\l's = 0. 40 
Degreem of Sum of Mean 
freedom squares square F-ratio 
68 4539.6779 
1 1205.6598 
16 1402.34.91 87.6468 5.96 
3 311.7669 
3 454.961.1 151.6537 10.32 
19 782.7325 41.1964 2.80 
26 382.2085 14.7003 
13 40.0443 3-o8o3 
13 342.1642 26.3203 
Covariance ma.trix/14.7003 
• o68402 • 010294 -. 001184 -. 026902 
.009742 .o69730 -.001696 -.029373 
• 000368 • 000408 • 058516 -. 002472 
-.017798 -.019718 .005079 .119461 






The treatment X mediator plus the patien~ X mediator interactions (eliminating 
treatments, visits, and patient ettects) h ootained by subtraction. First the 
treatment sum ~t squares for all tour visits atter eliminating visit effects ·t)ut 
ignoring interaction effects is computed. This sum of squares and the residu~ sum 
of squares in Ta'bles 4 and 11 are subtracted from the patient X visits (ignoring 
treatment) sum of squares to produce the interaction sum of squares described above. 
This interaction sum of squares was not partitioned into its two component parts as 
it would ·be necessary to solve 1 + 34 + 8 + 4 normal equations for the various 
effects to do this. Each of the observations in Taole 10 probaoly should be trans-
formed by nru.ltiplying by 0.4 oefore performing a coml)ined analysis. Also, a .loga-
rithmic transformation of the data in both Ta:bles 3 and 10. may ·oe sufficient to 
equalize residual variances for the two mediators. Despite the need for a trans-
formation, there is little doU:bt of the significance of the treatment and patient 
effects or of the interaction. A transformation to achieve stability of variances 
usually increases the significance of the results. 
A study of the visit effects indicates a lack of confounding between treatment 
C and the fact that the randomization was restricted such that treatment C appeared 
only in either visit 5 or 6. Since the C effect was so much larger than the remain-
ing effects, the visits 5 plus 6 effect should ·oe larger than the visits 3 plus 4 
effect where C did not occur. This was not the case, most likely indicating that 
the randomization restriction did not confound treatment C with visits 5 and 6 
effects. 
The treatment design was such that a mixing or interaction effect of treatments 
can be estimated. First we shall study interactions using an unconventional approach 
(see page 169 of Federer, loc. ~.)and secondly> a more conventional approach using 
the anal.yses for a 2 x 2 factorial. From the treatment effects given in Tables 4, 




... Histamine; . . Methachol..ine H + M 
Level of S 
' 
Level ot S Le"9"el of S Level of S 
Level of·I 0 1 . 0 ,• ~ . l 0 1 0 1 
" 
,., 
-1.26 -2.46 0 P=X Sc.X+.U. ~.:::-0.03 ~2.03 0.52 0.99 
. . -··~ .. • t.. ~ ,_ . 
" 
.... 
" " :-3.44 -1.~ 96 0.18 1 I.= X:+: v S +I- P- -2.Zl -5.41 -3·27 
.... 
" " " 3. 51 + 3. 44 = 6. 95 9· 47 + 5. 41 = 14. 88 4. 73 - 0.18 = 4. 55 Interaction C-S-I+P 
" .... .... . " .... Then, the zero interaction .may be computed as (P = x) + (S- P = u) +(I- P = v) = x + u + v 
"' " " 
= S +I - P • Any deviation from this value, . either up or down, is interaction. The 
observed C- (S +I- P) is a. measure of the interaction. This, except for a multiple 
of 1/2, turns out to be the interaction estimated from a. 2 x 2 factorial which is 
A A A A ( C - S -I + P) /2 • 
Now consider a 2 x 2 factorial analysis. Construct the following 2 x 2 tables: 
Histamine Methacholine H+M 
Level of S Level of s ·.~ ·. . Level of S 
Level of I 0 1 ,,. Sum -0 1 Sum 0 1 Sum 
' 
., . 
0 -0.03 -1.26 -1.29 -2.03 o. 52 -1.51 -2.46 0.99 -1.47 
1 -2.21 3.51 1.30 -7.96 9.47 1.51 
-3·21 4.73 1.46 
. 
Sum -2.24 2.25 0 
-9·99 9·99 0 -5·73 5.72 0 
Twice the main effects and interactions are: 
H M H+M 
Main effect of I 2.59 3o02 1.93 
Main effect of S 4.49 19.98 u.45 
Interaction 6.95 14.88 4.55 
Here we see that the effect of treatment I is positive, i.e. the presence of I 
minus the absence of I produced a positive value, and is a relatively small effect. 
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The effect of the presence of treatment S ever its absence was quite large, as was 
the positive interaction effect. The variance of 2.59 is obtained as (from Table 4): ~ 
3-o8o3[ .1574CYT + .144734 + .168660 + .494019 + .024632- .046163 + .o63884 
- 0 - 0 .. 0 - • 013158 + • 092105 + • 008373 + • 003589 - .1&622 - • 070574] 
= 2.6()866 
'lbe 95«Jt comparisonwise confidence interval is 
2.59 ± 2.160(1.615) = 2.59 = 3.49 
Thus, the effect of adding treatment I is not significant at the 5% level. The 
other effects may be handled in a similar manner. 
A Statistical Ana1ysis for the Data on Forced Expiratory Volume (FEV) 
for Visits 3 and 5 
Data for forced expiratory volume (FEV) was transformed as follows for FEV 
data at zero minutes, five minutes, 15 minutes and 30 minutes: 
FEVj 
I I I 
:a :b •C 
------~----------~-----------------1------------------------- Baseline 
-':--___ ..._ ____ ....._ _______ .L------~'---------
0 5 15 30 
Time minutes 
The FEV zero reading is subtracted from each of the five-minute, 15-minute, and 
30-minute readings to give values a, b, and c respectively. The area under the 
above curve is computed as 
Area = 5a + lO(a +b) + 15(b +c) 
2 
.. :-29-
The values a, b, and.c_~y be positiv~ 9r negativ~. Thus, the,..areas can be nega-
tive. Since Mr. William. Holt found tha-t are& values are very variable 1 it would be 
best to take square roots of areas. Since some areas are negative, a constant needs 
to be added to make all values greater tban zero. We arbitrarily added 500 to all 
values and then took square roots to obtain the data in Ta.bJ..es 13 and 14. 
Treatment I gave the largest effect with C following •. All treatments I, C, 
and S are ·larger 'than the placebo, P, treatment. A more detailed analysis following 
._, ~ ' ._ 
that in earlier sections could be followed. However, another approach was decided 
. ~ 
u.pon. This wa.s !because interest centers on the characteristic measurement, for 
expiratory volume (FEV) in this case, at the initial reading, that is zero minute, 
and then at five, fifteen, and thirty-minute intervals. 
It was decided to study the data from visits 3 and 5 for each treatment P, I, 
S, and C • The data for FEV for each of the treatments are presented in Tables 15 
through 18. A two-way analysis of variance for orthogonal data was performed, a 
least significant difference = lsd = t 05 X 
· • , error d. f. 
/variance of a difference between two time means, and the coefficient of variation 
.:t. 
= (residual mean square)2 + the overall mean. F-values for patients and times and 
tabulated F-values are also presented. The patient-to-patient variation for FEV 
is very large compared to the residual or times mean squares. Likewise, the time-
to-time variation is relatively large for treatments S and I and near expectation, 
24/22, for treatment P • The latter was to be expected since the P treatments 
should not affect FEV at any of the time readings. A summary of significance state-
ments for the time means by treatment and using a t-test of significance is 






















Table 13. Square ~o.ot of area pl~s .,500 tor forced 
expiratory volume (FEV). 
Visit 
3 4 5 6 
30.822 41.982 11.402 46.341 
48.811 48.244 41.443 10.000 
42.603 27.568 19.494 33-504 
28. 59~ 24.393 32.442 43.590 
53.385 25.690 37.483 41.079 
48.~96 28.638 28.240 17.819 
35.143 i 30.578 47.828 46.824 
22.583 48.913 5.244 42.3o8 
32. 7&7 36.912 32.939 34-315 
26.833 19.300 28.157 29.453 
42.367 26.458 29.707 36.332 
14.318 31.345 38.013 15.81.1 
14.748 I 26.833 5-916 25.397 
I 16.508 31.305 39.655 40.435 
?9.707 I 3-536 27.568 40.589 
49.219 42.397 ~7.932 54.863 
l9 .. 685 42.749 36.469 33.653 
556.407 536.841 509.926 592.313 
y = 366.115 
• P• y = 669.737 • I • 
y = 5()9.881 
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Table 14. Analysis ot vari~nee. tre~tment and visit effects, 
and covariance mat#ces for data in Ta:ble;~3. 
Degrees of Sum of Mean 
Source of variatien freedom s~a.res s~uare F-ratio 
Total 68 8o817 .5 
Correction for mean 1 7o884-7525 
Patients 16 3041.1884 
Visit (ignoring treatment) 3 212.0837 
Patients X visit 48 6679-4754 
Treatments ( elitninating 
visits) 
... ..3 2834.6121 944.8707 11.c6 
Remainder 45 3844.8633 85.4.414 
Treatment effects Covariance ma.trix/85.4414 
" 7·354 I = .008402 .010294 -.001184 -.026902 
" s = - 2.028 .Q99742 .o69730 -.001696 -.029373 
"' 
-10.854 p = .000368 .ooo4o8 .058516 -.002472 
"' 5.528 c = -.017798 -.019718 .005079 .119461 
Visit effects 
" v3 = 1. 756 
"' v4 = -L4gr 
A Same as above 
V6 = -1.140 
A 




Table 15. FEV cSa.ta for vis~~~ 3 ~nd.. 5 tor the P treatment 
and an anal.ysis ot -~ari~ce of' ~he data. 
Patient 0 1 .. 2 J Mean 
801 242 233 231 220 231.50 
.. 
803 330 332 324 322 327-00 
8o4 2o4 2Cf7 221 215 211.75 
8o8 349 344 354 347 348.50 
8o9 237 258 261 254 252.50 
810 240 237 251 254 245.50 
813 268 246 256 248 254.50 
814 242 234 234 233 235.75 
81? 253 260 268 236 254.25 
Mean 262.78 261.22 266.27 258.78 262.36 
* 0 = zero :m:l:rmte, 1 = 5 minutes, 2 = 15 sni.nutes, 
3 = 30 minutes. 
l)egrees ot SWil of Mean 
Source of variation freedom s~ares s~are F-ratio 
Total- Correction for mean 35 67320.3056 
Patient 8 65317.0556 8164.63 114.8 
Time 3 295.6389 98-55 1.39 
Patient X time = residual 24 1707.6111 71.15 
lsd = t. 05, 24 /2(71.15)/9 = 8.207 





_Table 16, F~ data for_ vis~11~. 3. a~~ 5 for the I treat!p;nt 
•' and_:·a.n analysis. pt. _va·riance ot the data. ' · · 
- . 
Time* (FEV) 
Patient 0 1 2 3 Mean 
8o3 
.. 
275 320 313 .. 342 312.50 
8o4 221 230 243 249 235-75 
8o5 222 316 308 298 286.00 
8o6 . 281 348 343 355 331.75 
acrt 293 347 355 374 342.25 
809 240 259 256 271 256.50 
810 243 254 255 251 250.75 
811 391 419 446 444 425.00 
815 245 241 261 257 251.00 
816 249 3(J'( 320 329 301.25 
817 231 278 265 238 253.00 
- ~: 
Mean 262.82 301.73 
____ ..... 305-91 309.82 295.(J'( 
* 0 = zero minute, 1 = 5 minutes, 2 = 15 minutes, 
3 = 30 .minutes. 
Degrees of Sum of Mean 
Source of variation freedom s~ares sg,1;1are F-ratio 
Total- Correction for mean .. 43 150008.795 
Patient •10 126241.045 12624.1045 46.45 
Time 3 15614.432 5204.81o6 19.15 
Residual 30 8153.318 211.m3 
lsd = t . 05, 30 /2(271. 7773}/1~ = 14.354 
' .. 






Table 17. FEV data tor visits 3 and-~ for the S treatment 
ahd an aaal.ysis ot variance ot the data. 
'l'i ¥ (FEV) me 
Patient 0 1 2 3 Mean 
SOl 238 246 264 252 250.00 
8o2 267 315 348 335 316.25 
8o5 203 197 249 253 225.50 
&17 286 331 298 319 308.50 
808 365 349 332 373 354.75 
812 241 211 233 245 232-50 
813 266 251 265 245 256.75 
814 237 278 273 279 266.75 
815 198 212 213 210 2o8.25 
816 236 325 294 290 286.25 
Mean 253·70 271.50 276.90 28o.10 270.55 
it 
- - -0 zero minute, 1 5 minutes, 2 15 .minutes, 
3 = 30 minutes. 
Degrees of Sum of Mean 
Source ef variation freedom squares s~ares F-ratio 
Total - Correction for mean 39 90859·9000 
Patient 9 75402.4000 8378.o444 20.03 
Time 3 4163.5000 1387.8333 3-32 
Residual 27 11294.0000 418.2963 
1sd = t. 05, 27 /2(418.2963)/10 = 18.769 
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Table 18. FEV data fW visits fl and 5 fe~ i;:.he C treatment 
and an ana1yils ef varf~e of tne ~ta. 
'-~ :; 
Time* (Fri't ~-
Patient 0 1 2 3 Mean 
8o2 298 335 342 350 331.25 
8o6 351 375 358 355 359-75 
811 441 454 456 454 451.25 
812 218 220 254 282 243.50 
Mean 327-00 346.00 352.50 360.25 346.44 
* 0 = zero minute, 1 = 5 minutes, 2 = 15 .minufes, 
3 = 30 minutes. 
Degrees of · · Sum of Mean 
Source of variation freedom sg,uares sg,uare F-ratio 
Total - Correction for mean 15 92817.9375 
Patient 3 87958.6875 29319-5625 108.28 
Time 3 2422.1875 807-3958 2.98 
Residual 9 2437.o625 270 •• 7847 
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Tzeatment C (4 patients) O" 5" 15" 30" 
---------------~-------------~-----------------------------~-~-~--------~~--------~------~--------~---·-----~--~~ t::~ii:Hfi#itfi~J::~mt.mMi#'¥£::¥;·tM;;:%$\;;:#;iiiJiiS 1sa 
o• 5" 15" 30" Treatment I (11 patients) 
-------------------------------------------------·----·-----·-----------------------------------------------------------
~ ,.:.:;"':'~:' '?.··*···;~.· .... -W-.~~'!' .. 0 Z.?~ ls4 
' ()" 5" 15 11 30 11 Treatment S ( 10 patients) ~ 
_ ...... -__ ..__ .... _~·-- -- ---...&.----- .. ___ .. ___ --------------- ... ---- .... ----------------------------------------------------------------- 0\ 
~':;;.~ ..... '">:- _ ....... -.,-.; '..... ..... ..... .:~~ ........ lsd • 
30"5' · ~" 15 11 · · Treatment P (9 patients) 
------&------·----~----------------------------------------------------------------------------------------------------lsd 
...___ _..._ -------- --~~ --~________.___--~~-------~~----------~ 
260 272 284: 296 3o8 320 332 344 356 368 
FEV values ... 




- N~ significant differences at the 5% level. 
S treatment 
- ~ans for 15" and 30 11 are significantly higher than the baseline, 0"1 
.mean a.t the 5% level. 
- The 5" mean is almost significantly different from the O" mean at 
the 5% level. 
- Remaining differences •f means not significant. 
I treatment 
- Means f•r 5 ", 15 ", a.nd 3n 11 are significantly higher than the 0 11 mean 
at the l% level. 
- Remaining differences between .means not significant at the 5% level. 
C treatment 
- No significant differences among pairs of means at the 5% level 
although the 15" mean versus the O" mean is almost significant. 
One striking fact about Figure 3 is that the 0-minute reading is so much larger 
for treatment C than for the remc..ining three treatments, Of course, only four 
patients are involved but it would be informatiYe to co:·:ga:':"e the means of patients 
802, 8o6, 811, and 812 from treaJGment C with the other t:c8e..tments as helow: 
Patient (patient mean and treatment) 
Visit 802 806 811 812 Mean 
3 316.25 - s 331.75- I 425.00- I 232.50- s 326.4 
5 331.25- c 359.75- c 451.25- c 243.50- c 346.4 
Patient (tero(FEV rean.ing and treatment) 
Visit 802 806 811 812 Mean 
3 267 - s 281 - I 391 - I 241 - s 295.0 
5 298 - c 351 - c 441 - c 218 - c 327.0 
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The patient means run 20 FEV points higher on visit 5 when treatment C was given 
than they did f'ln visit 3 when treatments S or I were given. Like1<Ti.se, for the zero 
readings only these four patients average 32 FEV points higher on visit 5 than •n 
visit 3· These four patients were about 35 FEV points a~ve the average ~f all 
patients receiving treatments P, I, and S. Hence, both sources of variation 
(sampling?) caused the means to be so far to the right in Figure 3. 
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A Statistical Analysis for FEV, VC, MMEF, SP, DP, and Pulse Data from Visit8 
31 41 5, and 6. 
The six characteristics considered in this section are: 
FEV - forced expiratory volume 
VC- forced vital capacity 
MMEF - (a respiration measurement) 
SP - systolic pressure 
DP - diastolic pressure 
Pulse - heart rate 
The data from visits 3 and 5, a table ef means, and analyses ef variance for these 
six characteristics are presented in Table 19 fer the P treatment, in Table 20 for 
the I treatment, in Table 21 for the S treatment, and in Table 22 for the C treat-
ment. The analysis of variance tables and means fer FEV appear in Tables 15 to 18. 
The data fro.m 'Visits 4 and 6, a table of means, and analyses ef variance for the 
above six characters appear in Table 23 for treatment P, in Table 24 for treatment 
I, in Table 25 f•r treatment s, and in Table 26 fer treatment C. The data was sub-
divided in this manner because the mediator histamine was given en visits 3 and 5 
and the mediator methacholine was given en visits 4 and 6. 
It was decided by the experimenter that the data frem all four visits should 
be combined. This results in 17 measurements on each ef the feur times ef observa-
tion, i.e. 1 0 = zero minute er baseline, 1 = five minutes, 2 = 15 minutes, and 
3 = 30 minutes, fer each of the feur treatments P, I, S, and c. The peeled .means 
of 17 observations were obtained as a weighted mean of the 3 + 5 and 4 + 6 visits 
means; that is, data fretn. all 17 patients were used. Instead of rerunning the 
analyses of variance, the residual sums of squares for visits 3 and 5 and for visits 
4 and 6 were cembined te ebtain a mean square with 45 instead of 48 ""' (17 -1)(4 -1) 
degrees of freedom. 
Table 19. Data and analyses for six characteristics for treatment P and visits 3 and 5. 
____ Q_B_S- PI\T VIT TRT TIME FEV vc MMEF SP OP· PULSE 
1 __ __!tl_9 __ 3 p 0 253 360 183 110 70 108 
2 819 3 p 1 260 363 206 112 68 108 
3 819 3 p 2 268 372 218 108 70 108 
If, 819 3 p 3 236 337 182 130 70 116 
________ _L 814 3 p 0 242 302 217 130 84 126 
6 814 3 p 1 234 300 203 130 82 122 
114 ----- _1_ _____ ~1_~ _____ 3 ______ p 2 234 306 200 130 86 
8 814 3 p 3 233. 302 203 130 82 118 
9 813 5 p 0 268 307 315 112 68 94 
,o 813 5 p 1 246 301 245 100 72 tOO 
- ____ u._ ----~J.~-- 5 p 2 256 291 303 110 70 86 
12 813 5 p 3 248 290 283 104 74 86 
1.~ 810 3 p 0 240 242 331 108 76 68 
14 810 3 p 1 237 239 329 100 62 70 
15 810 3 p 2 251 253 373 96 64 70 I 
+="" 
t6 810 3 p 3 25~+ 256 378 92 66 62 0 I 
17 809 5 p 0 237 239 329 102 eo 122 
18 809 5 p 1 258 259 456 100 76 114 
19 809 5 p 2 261 264 363 98 74 116 
~0 809 5 p 3 254 256 383 100 74 116 
?1 808 3 p 0 349 507 247 lL14 76 94 
22 808 3 p 1 344 501 238 140 80 92 
23 808 3 p 2 354 511 254 130 70 90 
?4 BOA 3 p 3 347 502 2'+5 126 76 88 
25 804 3 p 0 204 277 156 __ 118 7'+ 106 
~6 804 3 p 1 207 273 174 112 70-----w--
?1 804 3 p 2 221 310 150 100 64 92 
?8 804 3 p 3 215 270 202 108 72 8'+ 
29 -803 5 p 0 330 429 420 112 62 98 
30 803 5 p 1 332 443 &f. 54 110 72 tOO 
____ 31 803 5 p 2 324 421 410 118 68 94 
~2 803 5 P' 3 322 429 1H9 118 62 t02 
33 801 5 p 0 242 436 111 128 72 116 
34 801 5 p 1 233 420 108 124 76 tOO 
____ i? __ 801 5 p 2 231 439 116 126 74 94 
:56 801 5 p 3 220 401 105 114 78 tOO 
Table 19 (Continued) 
MEANS 


















__QVERALL_ r~EAN~- -~- __ 36 __ 3~4. 666667 264 .13888«L_ _ll.lt. 7222"-"2"-2 __ 72.6666667 9~_.. 111111 












MEAN 344.666667 c.v. 3.16072176 % 
Of SUM Of SQUARES MEAN SQUARE 
6 260353.500 32544.1675 
3 858.222 286.0741 
24 2848.278 118.6782 
35 264060.000 7544.5714 
MEAN 264.138889 c.v. 10.0445320 % 
oF SUM OF SQUARES MEAN SQUARE 
8 357112.556 44639.0694 
3 727.639 242.5463 
24 16894.111 703.9213 
35 374734.306 10706.6944 
' -r=-1--' 
I 
Table 19 (Continued) 
AN~LYSI~ OF VARIANCE FOR VARIABLE SP 
SOURCE 


















-CORRECTEo"- TOTAL -- ----------
MEAN 114.722222 c.v. 5.46100130 X 
oF SUM OF SQUARES MEAN SQUARE 
8 5088.22222 636.027778 
3 155.00000 51.666667 
24 942.00000 39.250000 
35 6185.22222 176.720635 
MEAN 72.6666667 c.v. 5.23183857 s 
oF SUM OF SQUARES MEAN SQUARE 
8 966.00000 120.7'50000 
3 31.11111 10.370370 
24 346.88889 14.453704 
35 1344.00000 38.400000 
-----------· 
MEAN 99.1111111 c.v. 5.04297424 % 
OF SUM OF SQUARES MEAN Sh'lUARE 
8 8143.55556 1017.94444 
316.44444 105.48148 
599.55556 24.98148 24 






Table 20. Data and analyses for six characteristics 
for treatment I and visits 3 and 5 . 
. Qs.S ____ .fAL . __ JLll ___ lB_T ____ T I ME F~E,_,V __ ---'-V_...C __ M~EL_ _ __,S"-!.P __ _DE_ PULSE . 
____ 1_ ____ 803_____ 3 I 0 275 391 206 110 -~8 ______ 102_ 
2 803 3 I 1 320 397 337 122 78 9~ 
3 803 3 I 2 313 395 334 120 80 98 
4 803 3 I 3 342 428 378 118 78 92 
.. ---~---- 8QI+._ ________ ~ ____ I _________ Q__ ___ _i_~l ____ n_~---- 138 ___ l_gg___ 82 l 0~ 
6 804 5 I 1 230 300 198 118 72 tOO 
7 _804_ ______ 5 ___ 1 ___________ 2____ ~4-~--~ll_ __ __j!_l~ 108 __ ___1_0__ 108 
8 804 5 I 3 249 318 235 110 70 92 
9 805 3 I 0 222 265 213 114 76 86 
,o 805 3 I 1 316 372 345 100 62 84 
_ _ti_ ___ ___§_O~ ______ . __ 3 ___ . _L _______ ~ . --~_a ____ ~_I_o ___ ·-··· ~2_7' ______ 12 ~--- __ _]_Q_ ____ -~ 
t2 805 3 I 3 298 363 295 116 72 9~ 
~---8_0~ ______ 3 ___ _1_ 0 281 301 443 130 90 108 
t4 806 3 I 1 348 432 363 140 80 112 
15 806 3 I 2 343 449 290 140 76 112 
t6 806 3 I 3 355 464 297 130 70 92 
t7 807 5 I 0 293 362 288 120 76 106 
18 807 5 I 1 347 410 ·--4l4 126 76 t20-
t9 807 5 I 2 355 419 _ 418 132 70 128 
,o 807 5 I 3 374 438 469 124 86 128 
21 809 3 I 0 240 246 337 100 70 130 
22 809 3 I 1 259 260 287 98 68 132 
~3 809 3 I 2 256 258 383 100 66 128 
-,-4·---8b_9 _____ 3 ______ f____ 3 -----271-273 ---· -456--100 ----~--~24 
'5 810 5 I 0 243 256 270 96 60 68 
- -,i; aio- -----5- --I--------i---2-54·----2~ ---4-o8 _____ 94-------6-cf ____ 72 
'7 810 5 I 2 255 257 381 96 62 68 
?8 810 5 I 3 251 253 372 102 72 60 
'9 811 3 I 0 391 ~70 381 108 72 9~ 
-- 30 ____ 8ii ___ 3____ I 1 419 474 48A 110 70 88 
~1 811 3 I 2 446 487 593 120 74 96 
-~- ----81i-- 3 I 3 444 504 547 116 74 88 
33 815 5 I 0 245 346 18~ 112 66 tOO 
34 815 5 I 1 241 325 197 110 62 120 
35 .. 815 . 5 I . 2 261 364 202 130 80 130 
--36- --- ··als _______ --5----f----------3 ----25_7 ____ 34i ___ 22o-- .112 12 - 118 -
37 816 3 I 0 249 268 248 100 66 112 
--3 8 816 - - -- -- --3--- --z----- - --i -- -- 3 o 7---- -386 ___ --26-4 --iTo--- 6 8 11 o 
39 816 3 I 2 32o 360 319 98 sa 96 
40 816 3 I 3 329 415 286 100 66 ~8 
41 819 5 I 0 231 324 183 114 72 10~ 42 -819 ____ 5 ___ 1 ________ 1____ 278 375 237 128 74 106 
43 819 5 I 2 265 358 212 110 72 118 
·· 44 _____ a19 _______ s ____ c__ 3 23a 323 2o3 126 10 100 













320,454545 262,818182 111,454545 73.4545455 
361,909091 321,636364 114,181818 70,0000000 
366,727273 334,272727 116.181818 70.7272727 






OVERA~L ~EANS 44 355,909091 313,954545 113,954545 71.8636364 102.454545 
AN~LYSIS OF VARIANCE FOR VARIABLE VC MEAN 355,909091 c.v. 8,20389468 I 
SOURCE OF SUM OF SQUARES MEAN SQUARE 
PAT 10 185794,136 18579.4136 
----
TIME 3 19331.091 6443.6970 
RESIDUAL 30 25576.409 852.5470 




ANALYSIS OF VARIANCE FOR VARIABLE ~~EF MEAN 313.954545 c.v. 15,9161932 I 
SOURCE oF SUM OF SQUARES MEAN SQUARE 
10 344394,409 34439.4409 ---------------PAT 
., .,._ .. __ '36 13280.8788 
64 2496.9621 





Table 20 (Continued) 
-------------
ANALYSIS OF VARIANCE FOR VARIABLE SP MEAN 113.954545 c.v. 5.73452822 ~ 
SOURCE oF ~UM OF SQUARES l't1EAN SQUARE 
PAT 10 5054~90909 505.490909 
~ 123.'::110~09 
------- ______ __:_ ____ -----:;-----,;~j()Q()g-
TIME 41.303030 
RESIDUAL 30 128t.09091 42.703030 
---------------------CORRECTED TOTAL 43 6459.90909 150e2304lf.lf. 
ANALYSIS OF VARIANCE FOR VARIABLE OP MEAN 71.8636364 c.v. 7.lf.7163099 I 
SOURCE OF SUM OF·SQUARES MEAN SQUARE 
PAT 10 1036.18182 103.618182 
TIME 3 102.09091 34.030303 
-RESIDUAL 30 864.90909 28.830303 
CORRECTED TOTAL 43 2003.18182 46.585624 
\._ 
\ 
- -·- - ...... 
ANALYSIS OF VARinNCE FOR VARIABLE PULSE MEAN 102. 45'45lf.5 c.v. 6.93088129 I 
SOURCE OF SUM OF SQUARES MEAN SQUARE 
-PAT 10 11498.9091 1149.89091 
TIME 3 347.2727 115.75758 
RESIDUAL 30 1512.7273 50.42424 








Table 21. Data and analyses for six characteristics 
for treatment S and visits 3 and 5. 
__ .o.as_ ___ PA_l __ y_ll_ __ l!H~- _llltl:~---E~~V ____ 'it_~_Mm:f ___ ~_P _ ____OP_ PULSE 
__ l _ JU6 ----~--- ___ S __ 0__ ~3~ ______ -~6.-~--- _ -~f,L _ ~__Q._ ____ 66 _ -------~~ 
2 816 5 s 1 325 424 284 110 80 84 
3 816 5 s 2 294 358 268 114 70 82 
4 816 5 s 3 290 359 258 120 70 74 
~--5~---~1 5 ---- 3 s 0 19 8 . 2 8 8 141 13 0 8 0 1 0 0 
6 815 3 s 1 212 305 164 126 78 96 
__ 7 ______ ~-~--~-3~ _ __S ______ 2 213 Ml_____ 162 138 80 !08 
8 815 3 s 3 210 291 156 140 78 118 
9 814 5 s 0 237 320 194 128 80 130 
10 814 5 s 1 278 294 288 132 92 110 
_ __l_L ___ -~l~ --~---5--~~----- 2 273 336 263 124 90 120 
12 814 5 s 3 279 346 271 128 88 126 
_ _l_~ __ __l}l_3 3 s 0 266 324 275 114 78 104 
t4 813 3 s 1 251 313 245 100 72 92 
15 813 3 s 2 265 312 291 110 70 92 
16 813 3 s 3 245 292 248 104 70 88 
17 812 3 s 0 241 333 175 120 76 110 
1 8 812- 3 s 1 211 311 1 3 0 12 4 7 4 1 0 6 
19 812 3 s 2 233 341 164 116 66 106 
20 812 3 s 3 245 338 181 122 78 t04 
21 808 5 S 0 365 524 254 144 84 tOO 
22 80~ 5 s 1 349 484 240 130 82 112 
,3 808 5 s 2 332 491 213 140 84 106 24 -------86A __ 5 ___ s--------3---373 ____ 536 ----268 ___ I22 - -80 ___ 106_ 
25 807 3 s . . . 0 . 286 370 254 118 78 t02 
,6 ---£fo7 _____ 3 ____ s--------- ----1----331 409 -----326 _____ 116 10 ________ 108 --
,7 807 3 s 2 298 406 229 118 72 114 
,e 807 3 s 3 319 387 326 110 80 110 
--- '~- -- ~9!5 ____ 5 s 0 203 241 208 112 64 80 
~o ao5 !i s--------------1 197 24o 1-91 110 68 82 
31 805 5 s 2 249 290 254 108 68 76 
32 805 5 s 3 253 296 272 108 66 80 
33 802 3 s 0 267 487 125 138 72 134 
34 802 3 s 1 315 481 189 132 68 114 
35 ___ 8_0___? ______ 3 ----~-- 2 348 447 321 114 58 116 
--36-- ao2 3 s -----3--335--~~----~ha 116 66 110 
-~·u ____ ~Q_L ____ ~-~-s o 238 416 120 112 12 11a 
38 801 3 s 1 246 436 120 120 84 116 
39 801 3 s 2 264 457 123 122 78 110 
40 801 3 s 3 2~2 442 122 118 74 102 























73.60000 0_!)_ _ ____1_03. 000000 
75.0000000 101.800000 
-----------------------------------------------------------------· ··-----------------------
OVERALL MEANS 40 372.300000 












217.300000 120~700000 75.1000000 103.450000 
MEAN 372.300000 c.v. 5.90152077 " 
OF SUM OF ~QUARES MEAN SQUARE J:":.va.lc.~e 
9 237658.400 26406.4889 
3 748.000 249.3333 o.s~ 
27 13034.000 482.7407 
39 251440.400 6447. f897 
----- ----
MEAN 217.300000 c.v. 17.8510005 I 
OF SUM OF !;QUARES MEAN SQUARE F- \>'a.ILA e. 
9 102357.400 11373.0444 
3 10~60.600 3520.2000 &. 3-il 
27 40626.400 1504.6815 





Table 21 (continued) 
ANALYSIS OF VARIANCE FOR VARIABLE SP MEAN 120.700000 c.v. ~.251+43181 ' 
SOURCE OF SUM OF SQUARES MEAN St:lUARE F-=\Ja/k.e. 
PAT 9 3128.1+0000 347.600000 
TIME 3 126.00000 42.000000 /, o'l 
RESIDUAL 27 1086.00000 1+0.222222 
CORRECTED TOTAL ----3----c9=------=-4--=3:-4--=o-.-,--4--=-o--=-o--=-o-=-o---11-1-.-2=-9-=2.:-:3:--;0~e:--------------
ANALYSIS OF VARIANCE FOR VARIABLE OP MEAN 75.1000000 c.v. 5.99009246 " 
SOURCE OF SUM OF ~QUARES MEAN SQUARE F'-"Vlllke. 
PAT 9 1625.60000 180.622222 
TIME 3 51.60000 17.200000 o. ~ -- -
RESIDUAL 27 546.40000 20.237037 
CORRECH:o TOTAL 39 2223.60000 57.015385 
------:;-f 
ANALYSIS OF VARIANCE FOR VARIABLE PULSE MEAN 103.450000 r.v. 6, 76066960 ~. ~ 
SOURCE OF SUM OF ~QUARES MEAN SQUARE t-\IA.It.c. . 
---------
6974.90 0 0 6---774.988889 j PAT 9 
-----
58.766667 -/.9.. 0 TIME 3 176.30000 
RESIDUAL 27 1320.70000 48.914815 






















Table 22. Data and analyses for six characteristics 
for treatment C on visit 5. 
VIT TRT TIME FEV vc MMEF SP 
5 c 0 298 455 171 110 
------ _"S ___ ----- -c ------- ---- --·-
-1-- --~-s--4~-----~q--!"3"0 
5 c 2 342 499 226 120 
5 c 3 350 486 248 124 
5 c 0 351 457 313 136 
5 -----c--- ------1--~-- 499 - 310 138 









----~- c--- -- - ----r------35~---------qr-1-- --2--a-1- 13(}-,-u--
5 c 0 441 504 511 112 66 
5 c 1 454 505 574 114 70 
5 c 2 456 521 562 110 68 
------s---c ----------~ q54 -- 512 ~----112 72 
5 c 0 218 349 200 118 78 
-- ---,-.. f3T~---- ---s -------r- -------1------~---lnre------18 s 120 70 
t5 812 5 c 2 254 344 202 124 74 


















Table 22 (Continued) 
ANAL YS lS~~\.fAR I ANCE F'1lR~ VAR I ABLF" SP MEAN 12T~62~ooo c.v. lf;-08579692 ~ 
SOUI~Cr OF SUM OF SQUARES MEAN SQUARE F~ u~ fu -e, ;::.~ 
PAT ---~~-- 3 1126.75000 375.583333 
~-IT~-------~---------~~~----- 3 108.75000 3""b-25lJ"OlJlf-~---), J./ 1 
.J. ib 
R£STDUAT -.:r-----z22~;"2"5U"Uu-- ---"2"1J ~"b91.J~c.J~ 
-----cORRECTm--TOTAl-----:-----------------------rs-H-----l--q-s7. 75000 """97. 1 e 3~---
ANAL Y S fSCYF VARIA NrrFlYR"· ·vARIABLE'~~ ME:AN - - 70;3750000 c.v. ..,.,0092472-. 
-- SOIJRCT OF smr-OF sQUARES "MEAW SQOARE r- {);11A (.. f"f' 
~ PAT ------------------- r-- 1 12 • 15 o o o o 57 • 5 a 3 3TI"3 
TIM£ -----~ 6 ~750-~ 2 • 25U"QO"UU ,f) 7 J.{~ 
RESIDUAL ~- 276.250000 -~~fi607 
- CORREC I ED r OTAL --------- 15 '+57 • 7500UW 31l.-sftt6667 
ANAL YSISO~r-VARI r.Nt_t_FOR_VARlABLf POLSE MEAN 1()8;125000 c.v. '+ • 2 o 1 21 31 o-~ 





3 U92--;7s o n-o--~. 91 "b6b'f 
----3""~~-- ---- 9 2. 75 0 0 {f 311.91bb67 
~ 186.25000 2~~qqq 
--~--------rs· 1571.75000 '10~ 783333 










Table 22 (Continued) 
MEANS 
N vc MMEF SP OP PULSE 
441.2 50000 298.750000 119.000000 70.0000000 104.000000 
4 476.250ooo 32o.7soooo 12s.sooono 69.soooooo 11o.oooouu 
4 459.500000 318.750000 122.500000 71.0000000 109.000000 
4 464.suoooo 32t;srro-uuu- 119.50~---rr.ooouuoo I09.50ooou---
----------------------------------------------------------------------------------------------
OVERALL ME~NS 16 460.375000 314.937500 121.625000 70.3750000 108.125000 
ANl-LYSIS OF VAlrtliNCE~ VARIABCE--VC MEAN 460.375000 c.v. ~69565750 ·-s 
SOURCE OF SUM OrsQUARES --MtAN SQUARE I=' -IJtdi!t. 
3 43916.2500 14638.75-uo 
Fo~ 
p-JT 
-TTMr- 3 2542.2500 847.4167 ~.93 ~3~?, 
RESTUUlfL- --- ----~----------~-- --~blf5. ZS u-u- -- --2-8 9 ~722 
CURRTI TED T 0 T A[ -~---------- rs- 4'1-(f~. 75 0 0 3270.916(-
ANALYSIS OF VARIAN~FlYfr\IAR I ABLE t#MEF MEAr 314.937500 C. V • 7 • 50842692 ~-
SOURCE OF SUM OF SQUARES MEAN SQUARE r-hfq ~ 
PAT 3 3T735-o • 6 a a 105783.563 
TIME ------------------~----- --y-- 1413 • 6 8 8 - ----'f'7r;-zz9 (), ~ ~ 
RESIDUAL 9 5032.563 559.174 





ORS PAT VIT 
-52-
Table 23. Data and analyses for six characteristics 
for treatment P on visits 4 and 6. 
TRT TIME: FEV VC MMEF SP OP PULSE 
1 802 6 p 0 244 435 104 112 70 116 
2 8o2 6 P · ·· ·· -1 -···· ·23·2·· - ··· 359 -- 142·----fnr· - · 66 i2ll 
3 802 6 p 2 227 387 106 128 78 t20 
___ i+ _____ aiJ2 · ···· --6---rr-------r- 231 376-----·-·r23 ___ i_o~-·--s2 116 
5 805 4 p 0 240 294 235 100 70 88 
6 8 o 5 4 P 1 - 2 3 9 2 9 7 2 31 f(f6 - -6 4 · - -- --·11o· 
7 805 4 p 2 239 311 207 108 72 90 
a ··ao5· 4 P 3 26L.- 348- ·228 J.o4 ___ 74-- -----lf4--
9 806 6 p 0 369 476 315 140 70 86 
---,-u·---so6_______ 6 ··-p----- ·------1-~7---4h5- --3-4-cr- -- 134 78 as 
11 806 6 p 2 361 480 272 124 70 90 
12 806 6. P 3 360 502 2·29 ---T24- ···- --;6- -----92-
13 807 4 p 0 308 362 282 114 80 104 
14 807 4 P ... 1 - 30.9 399 2b7 - ·112- ----78-- -- ----yQ1f -
15 807 4 p 2 326 409 305 110 82 98 
------,-6--------- --a o -,---- 4 --- -p ... -------- 3 -~-~ ···-4-i"4-------~~----112 ______ ,1i ___ .. _______ ~-rn·u-
17 811 6 p 0 369 469 402 106 68 88 
18 Btt -6- -- P 1 408 · · 42o 421-- 13:4 --6a ----- as 
19 811 6 p 2 401 466 473 116 68 t08 
,o 811 -6 -·-- P 3 3S"E; - - 4"55 41A ·- r-o-a-- ---,4-- ----- ··Slr-
'1 812 6 p 0 238 390 146 126 76 102 
_2-~----~12 --·-----6- ·---··-g-··-----------1--- 21s l.f02-- ----i~r------rlfcr------,o-----~-
,3 81' 6 P 2 236 398 158 140 AO 102 
2 4 a 12 6 · P 3 ·· 2·3·1 · 3 95 13 s 13 2 -.- 16 ---- ro~ 
25 815 4 p 0 237 336 179 138 82 120 
26 815 4 P 1 212 292 166 130 80 1ZU 
,7 815 4 p 2 222 311 172 132 80 t24 21!- --·ar5·· ----4------p·------------3"·---~""22 ____ 32o ---16b"--i~ as-·· 116--
'' 816 4 p 0 214 280 182 104 60 108 
30 816 · 4 · P 1 268 3~ 270 ·· Iu-a·· · - ·orr -- ""90-
31 816 4 p 2 250 289 245 106 70 98 
32 816 ij p 3 2"73 ""332 . 250 -· "98 64 96 
Table 23 (Continued) 
MEANS 




e . 277.375ooo 3e0.250ooo 210.625000 117.5ooooo 
- ---- e----2-et-."25-tfooo _____ 367 .125ooo 247 .8750oo 120.25oooo 72.0000000 101.500000 ---n-~lHHrooo n---i oQ.751JlfO-o 
3 8 282.750000 381.375000 142.250000 120.500000 · ·-a--·-·287;7soooo-·-~392 .'15ooon 215 .375ooo ___ 1t3.75oooo 7s.ooooooo 103.7soooo 
'72.7su-cnfo(J- ----1 o 1 • o cnnnro 
-·-~-----------------~----------- --· --------- ~- ------------~-·------------------------------------~------~--- ·------------·---------- ·------------------------
~- --------- ----- --- ---
OVERALL ,_EANS 32 282.281250 
-------
3~~~-~7500~ __ _!_39.,Q_31~~0 -- _!1_8_!~~0000 72.6875000 101.750000 
- --- -ANALYS-ts-·o·r V-ARI4riJC:t--~OR VARIABi..EFE_V ______ -----MEAN-----282.281250 c.v • s :Is 4 O'fioa 1-
... sot.IRfE···-----·-·--·- --------
oF SUM OF SQUA~ES F--,Ta-7v. ~ 
--PAT ---- --- -- ---.,------l23349-;21 4i 
I'IIEAN SQUARE 
17621.3170 
f1ME. --------- 3-· 
· 44-2-~094 -------147:-3646---- ·o-.7r--
- -lfLstou-ic ---- ·- .. ·----~---------- -------~--- 444~6· "2fl.b'1lf 1 
C'ORRtt~TEo IOTAL. ~I 128236 ~-469 ------ 4f3E;-:t>t:.-cr3 _________ -
If~ L ~ ~- J ~ ~. _2tjz -~- --~ ro.; (~~~ ~!_--:- ~. () 1 7-:;·(~ i/f;---1, gj- ~ 
-------- --- - --~ -- ----
ANALYsts- CfF-YARTA'NfE-F"OFC-VAR!ABLEvc ____ -- MEAN --- 380 • 375(fOO c.v. ·s-;4216a7e6T __ _ 
--·sou"Rcf·-----~---·· -· --- --·-···-----· oF SUM OF -SQUARES--MEA-N SQUARE F- Vc:t "ft.t-.. 
PAT - -···-- r ---·-T24i64·.-soo ---T77s2:o714. 
TlMt- ---·-- -- --- 3--------2637~75cf ____ 879-:-2stnr- --- -Cff.7J-'l-· 
RE~lbOAr . -. ----·- -2i---e931".25o----~. 2976 ------------·-






Table 23 (Continued) 
ANALYSt~ OF VARIANCE FOR VARIABLE ~MEF MEAN i39.031250 c.v. 
soLrR·c·r- ----- --------~ -- ------------------ ---------o~r: 




ANALYSIS OF VARIANC-E FOR VARIABiE SP 











46o.28f3 - o.s-a. 
Ef84 ~-61.'f6-----·--·-
c.v. 4. 73c 
SUM OF SQUARES ____ MEAN-SQUARE F- ~a(~-~ 
4444.00000 634.857143 --
2 37. o o o o o 79-~ o o-ooo-o --- ~. 3" .3-
--- ___ 21 --·-- ~ s-c;-.-u-~rorro--------3I~l9114f6 ___ --- ·-




- ·- --···-·-···--···----· ------ ---·-·--- ---··----------51!-sDMOF SQUA-RES MEAN-s-oDAR E -f:_v;,~-z 
-156--. 553-57"t --- ---------------7 1095;87500 
TIME .. 23. i~fs-on'o -·o:K'f 
· -·-· -·---- · -- -------- ·----· ---·-· · --- ··--- -· · 2 r· --- -----~. 6 2soo--· · ·-rr;4i(rn 4 
. R"ESH.5Ui\l 
CORRt:Cn:o TOTAL 31 ·17~o.8r5oo· s~.t5r25a 




·--------·-or-slff-1 --0 F s QU Afff:"s--·ME AN -s QuA RE--F- u~/-;:; 
1 3890. ooooo ·ss·s-~714-286 ___ - ···---· 
3 45.00000 15.00IJOCfO ___ -o.-t,7· 




Table 24. Data and analyses for six characteristics 
for treatment I on visit 4. 
TRT TIME FEV vc MMEF SP DP PULSE 
1 801 4 I 0 205 374 100 112 88 116 
2 801 4 I 1 251 414 137---106 --78 -126--
3 801 4 I 2 252 449 112 108 72 104 
----ti --- --ao-1· ------4-----i- --------_ -- 3-----249 ___ 45"4-- ----1-16- ----Ioa-· --6-a- 112 
5 802 4 I 0 231 411 103 112 66 118 
6 802 4 I 1 300 - 413- 168- iOi-- -----60 _______ 112' 
7 802 4 I 2 304 456 183 112 68 116 
& 802 4 I 3 -28ti 413 199 1f6-- 76 --- -ii8 
9 BOB 4 I 0 331 511 204 122 80 96 
---,.--o·----80 8 4 I -- ---------1 3 7 9 -5T4--~ f2 ________ f 2 4 78- 1 o 2 
11 808 4 I 2 408 544 343 134 74 92 
12 808 4 I 3 407 551 316 128- - ·90- -"9ij" 
13 812 4 I 0 245 341 178 110 66 118 
t4 812 4 I 1 264 361 194 124 70 i12-
t5 812 4 I 2 259 358 18A 116 72 116 Ii, --- SI2-- ____ ij _____ r___ -- ______ ""3"' ______ 2_6'( ____ ~76-- ---T87-- -- I12------6·e---- --- - fi""B -
17 813 4 I 0 280 312 360 104 60 100 
,a 813 4 I 1 284 316 342 110 60 106 
19 813 4 I 2 288 307 398 104 60 tOo 
?0 A13 4 I 3- 292 310 404 1t2 ---62- --yuu-
?1 814 4 I 0 266 326 264 140 76 t34 
-n------a1.·4·--------cr ----1---------- 1 ----z91-- _3'5"U _________ '3"f!r- --rr~-·--a·o ·- 13o 
~3 814 4 ! 2 264 346 294 130 84 t32 
'-'r 8T4 lf -- - I 3 275 3'+0 265 _ 13'0 84 -l2'b 
Table 24 (Continued) 
~-~~----~-- ------· - ---
_ ~--~_l~O ... _W~_'r -~LASSJ£j_CAT_tQ~ --·- ____ _ 
MEANS 
TIME N FrV --~---JLc; MMEF SP OF' PULSE 
0 6 259.666.67 379.166667 201.500000 116.666667 72.6666667 113.666667 
1 ~ ------~--6-- -~. 8 3 3 s 3! -,. o 4 ~ 6 6 6 6 b 1 ----- 24 3. 8 3 3 3 3! --- Tf4;TI 3 333-~--,1~- o-umrou-cr-~11lf ;t~ 6-6667 
2 6 295.833333 ~10.000000 253.00~000 117.333333 71.6666667 111.000000 




OVERALL MEANS 2 .. 286.500000 .. 00.291667 236.541667 116.500000 72.5000000 112.666667 
----~---· ·---=-=--""'=----=---:=-=-::--==.o..=-..::·-------~-:::----=---~=--=-=------;:::::-:::::-_--==-:::--.~--::-=:-:-==:;.._--=---:-:---------- -------------
ANACY-SI s· OFVAR n1~NU--F-OR -VARI ABCt FEV _____ ------- -- ~- ---- ----y--;- .,.l'\ji--o------ -- ----~ ---~-----.-zr------MEAN 28o.5uuv0 c.v. 5.6~, 
SOURCE ----~--------- o~OM OF SQUARES MEANSQUARE~~-
fiAT -4872<I;ooo o-~-- 97-45-;aocrrro-- --
TD'£- 3 . 5763.66b7~-·----f92T~-2'"2222~'/--------
RrSTCiU.If[- -·· - -·· --·----------------------·---- ----rs- - -----~25". 3"3'"3~----2l)1.6888«r··--- ---~ ------· 
CORR£1:TE:IJIOT A f.. - - -- ·----23 ------s-szrra-~ o1>-rm -- --2---s3'cr.9TI04--~~--
ANALYSIS OF VAFf:tANC-E FOR-VARIABLE- VC- ~-MEAN-~--'+ olf. 291667 - - c. v. -4. 83201853·--.-~ 
-SOURCE ---------------·--- -------·-----oF·~ SUM OF ~Q-UARrs-· MEANS QUARE f. u;r:.i;"-----
-PAt --- ------- 5 12-19 ry;·roa ----- ·;rss a2 : 3 411-
fl'ME: 
· 3~-- ---36-55~-,..-sa ---~-12t-s--:-,..-a61 ___ 3~-l[l~-- ~ -
---~ r-SJ tJUAr--- -·· --------~-----------rs--·---- 56 u.-"flJ2-··- 37'+. fPJ4 _______________ _ 






Table 24 (Continued) 
-NALYSI~ OF VARIANCE FOR VARIABLE MMEF 













10076 ~792-- ------ 3-358 ~ 13"306-- ij. 34/-
1 f610.-9·sa- 114. 0639 
116.500000 c.v. 5.127 
SOURCE-- ---- ------- ·- ----------------------- ----t5F-SUM··ar:·~QUAR"ES _____ MEAN SQUARE -,:-::-ut'-]t~oO 
PAT 
TI~E 
~rouic-· ------ - ----
eaRRECTro TOTAL - --- ---








'*0.66667 .. 1.3. 55555-6 
35-. 6a··sae~r.c,..-- ------ ----
- 24 74. ooo o o 101. 56""S2i-..,--- -------
f 
- -- ----- ---· ----- . - -~__:__ -:~~ ~- -- -:-:-·_~ 
MEAN 
1334.00000 266.-800000 
- Msl-DUAT______ ----------- --------------------··-rs-----~!e;uQOlJO 
C"ORRtCTED TOTAL 
ANAL~S~S OF VARiiNCE FOR VARIABLE PULSE 






tfntDUAL - ---------------------------- -------- ---r-s-·--------36A ~-6666;· 24.517778 
1 '+ 2 • 8 4 o·sa o 3285.33.33~ 
PAT VIT 
-58-
Table 25. Data and analyses for six characteristics 
for treatment S on visit 4. 
TRT TIME FEV vc MMEF SP OP PULSE 
1 803 ~ s 0 306 ~18 ~07 120 66 110 2-- - eo3 ---4-- -- s- --- ---------1----- ~15 ---- -~19___ 428--- io8- -- 60 --------In 
3 803 ~ s 2 316 41~ 446 100 68 ao 
----4--81J3--4---s-- -r-~-rs--lffl3 _____ 428 116 64 l"O"b-
5 eo~ 4 s o 243 310 223 110 80 8~ 
- -6- - 804 - ·4 - s 1 --- 23_2_ 3YO- --- ----182 -3:12--ri:r-- ----~--
7 80~ 4 s 2 253 319 248 108 70 8~ 
e eo4 4 s 3 2so - 32!-- 226 ----- flo _____ 7-o-------,r;--
9 806 4 s 0 366 454 384 130 80 t06 
--·-,-a-· ··-s-o-6·---·--,.---·-s--···-···· 1 36,--4Ts-· 330 _____ 120 __ -----rr 1o4 
11 806 ~ s 2 376 478 3~5 110 64 96 
1-2 805 4 s 3 39t 505 352 118 ?2 ·-·""9b--
13 809 ~ s 0 226 228 363 98 70 118 
1 ~ - -809 4" - s -- 1- -- 229 ----2~ -- ··341~- - -98 _____ 74 .. ··--·----fO"u-
,s 809 4 s 2 27~ 278 382 94 60 116 
---;-&----····lro·g----- 4 ··-s---·-----· 3 2sa ---~Eil----·~cr··-·--r-o-o··--~o--·-···-· ·-tflr 
17 810 ~ s 0 268 275 295 110 68 7~ 
,e ·-a-to- 1+ - s --- 1 26""4 -- -268- 3·21- - 9"2 ----;·o - ------n 
t9 810 ~ s 2 265 267 367 100 66 68 
20- Bl.o·-------1..----·--s-·-- --- --3-- ---260 --2b"2- 387 - roo - --,o---- ----------~-
21 811 4 s 0 332 ~04 322 90 68 74 
· -}2 ______ lfff-- ·-·----zr-·-s··------- 1 3'+9 ·-'+32·--·----"33-rr----·--92---·~ so · 
'3 811 4 s 2 342 453 283 88 58 78 
'4 811 -q s -3 32-5 - -- 4"22- - 273-- 92 -- -62- - --·----n---
,s 819 ~ s 0 219 3~1 1~6 112 70 11~ 
,, Bt9 4 s 1 273 375 z2o l-f4-- - -ao·----------ro-a --
'7 819 ~ s 2 270 351 227 108 70 110 
- ·--,--a·---·---apr--------ar----s·-------3-- 2!17 3'+9 · n-r· · 124 ·-----nr.. 1 oa 
Table 25 (Continued) 
MEANS 
-~--,-- -- ------~-- ----------~-
TIME N FEV vc MMEF SP OP PULSE 
-·---·-- ---·----·---·---
0 7 280.000000 3~7.1~2857 305.714286 110.000000 71.7142857 97.1428571 
--r 1 28CJ.a571~ ~.571429"" 3D8.oooo1llr ----ros-~~2857 7o;5T142a& ·"'JT.Tflf2~ 
2 7 299. '+28511 365.714286 328.28571 '+ 101.14285 7 65. 1428571 90.2857143 
--3 1 293. 71'+28&- !T3~uncfoo--- ~-;-urr01101r---10~. 57l-~~---e.s.omnr0lro----"""'Tf-;T4-2S511-
----- --·-- -~-
----------------------------------------------------------------------------------------------
·- . -r - -
ovt:FtAlL 21 290.750000 358.607143 316.250000 106.214286 68.8571429 93.0714286 
--~----- -- ------ --~----- --- ---- --------------
___ MEANS · .. V.I,. 
-- ---ANALYsts-OFVifRI l\NCE--FORVARIABLE FE-V~-- ----- MEAN 290.7sOoooc;v.~---4.q~----
- .. -5-0UR([----·-·------- ·-· ------ --- ---------
-----P-At ----------------------
-- - -TlME-- -
RESITJUAC 
- - ·- -CO'RRtiTE'O --TOTAL ____ __ 
------· --------- -- -·-- --
oF SUM OF sQUAREs MEAN SQUARE F- · 
-.L !OS!/:?. iJ~ v .. /,.4. 
1:1--, - 635f=.3. 3333 "1}98Bl' 
- z-~------I~2"'5llo- -- 'IT);.751ro·o--d.-y~.,.~-­
tJi6· 5'9~, 
·-rg- 28t8.6{;b7 7 iJille 
-- 2£- --··--6'77e-s-;25-o-o·----·2-sllr;st>'+"8r--------· ---
F/tJ {3~ l_i/_::_o_~. '! c1- . - • __ fA£ (~;ff)__=~~~/-~- ----~· ;=;, {3,) f) :.S,~,Cf 
ANALYSIS~-OF VAR-IANCE-rORVARIABLE-VC MEAN 358.607143 c.v. 3 ."'51f585351-~~ 
souRer·----------·-------------···---- .. ---.. ---·- -----oF suM oF sQUAREs MEA-N SQUARE F-11c:llle 
PAT .. --- _ .. ___ ----- ---- - -------------t;- -~-- ----17a96o.9-29 .. -- :S\ft~~r-
-rn;,r -----------·-.... --3-------·---~-14Cf8; 619 ______ 469-:-sslfS- -----'8'."07 ________ _ 
-~SIDUtrc--·----------------- /ft:f" __ ._.. 28llelr7f k~~'J'J~·'-------







Table 25 (Continued) 
3" . 2586.393-- -862~13f0--7.-,H---
TIME 
trCS-rOUA·c-···· ------·--·-------·----··-iT---:--fs~b0'7r--,~rA;o\~t~~~tg~"'~-
tO~RECi£C TOTAL .. 
1'.,. 
ANALYSIS OF VARIANC£ FOR VARIABLE SP MEAN 
soliRct-· . - -·-- .. ----- ------ --- -·- ···-·- ··------··----------orsu,.,··aF-~QUAFfE·s MEAN SQUARE -,-..;·--
tl;~;/li-~~ --~--~~_e. _____ _ PAT -J,· ----- 2S"s·q-;•n 4;f9 __ _ 
fDE 
"Rn"IOUAL·- -·-· --· ----- -· 
C"lmRECTro TOTAL. 
ANALYSfS ·oF \/ARIANCt FOR VARIABLE:-·oF,-----. 
SOOFfcE··--··-·-· 
. ..... 27" 
oF sUM OF sQUA-RES-~AN SQUARE F·ueltt< 
?~.193'~ -i,--------lf96~76190---~-1ifiiHfr.t ----·----PA-T 
TIME .... -- ---- ·- ·- '3 -- -- - li'f;cmrs,-----s-g-;a--tfCJS"2!e ---~f3- ---
RES 1 OUJQ----------------·-----------··· #· ~DGllll 1f "!b7.2381D jj tl t ~ 
. - 27 .... 
ANALYSIS OF VARIANCE FOR VARIABLE-PULSE 
-SOURCE---·····-----·-- ····----------- ······-····---·------·-=o:-.F.---=su:-7.M OF c;QUARES MEAN s-QUARE t-~~~~~ 
PAT b -_,- ·6s·a·3. 85-71~-- -- i~lf,-~{o ' ----
flMt .. 3 - 199.28571 . 66~428571-- /,53 




Table 26. Data and analyses for six characteristics 
for treatment C on visit 6. 
VIT TRT TIME FEV VC MMEF SP OP PULSE 
1 801 6 c 0 206 ~30 80 11~ 80 12~ 
- 2 801- 6 c 1 26 7 - -~2 140 -13-0 - -----.,e, ----1~~-
3 801 6 c 2 26~ ~4~ 134 122 72 128 
-----..--·~-so·i-- 6 c --·-----·· 3 26a --4,.-o-~---i-46·- 120 7tf _____ i2&. 
5 803 6 c 0 30~ 392 377 130 66 120 6 ao3 6 c -- y· -- 321 -c:.~-o·---- -- 4T3-- - --·fr6-- --·-cs-a------Iu£,-
7 803 6 c 2 337 452 462 110 60 96 
8 -g 0 3 --6- c 3- - 3-1!5 - .,. 39-- - - 4 lf8 - 112----- _7_0_ -- ---u~-
9 804 6 c 0 202 258 176 110 70 80 
---,o----ao-4· -----r--··c--------r------2~i---~4------nr9 118 66- 84 
11 804 6 c 2 257 330 247 110 70 82 
-,-2--- ·8n4 6-- c -3- -2~8- --36d T3_6 ____ 11ti- ----,o· ---sa-
1a 805 6 c o 228 211 235 98 66 84 
-,4 805 --6 -- · c 1 259 324 ·· ·:;r42 J.cr4 _____ 7o ----- ---- ac+-
15 805 6 c 2 27d 334 282 104 68 82 
-16 _______ -mJs -----;;-----c------ 3 212 ~~--- ---2s1r---urr-6r--· 80 
17 807 6 c 0 315 386 320 116 80 110 iS- a·o7 ·· · - -- -t; c -- ··1 -- _3_6_9 ·--422 ---- - - -476 - · __ 122 --·-ao-· -----rn 
t9 807 6 c 2 379 431 491 120 80 98 
~io 80-7 -- ----6 ---- c ------ -- ------~-----31HJ -- --'+lff ___ ----471+ ---- --n.-a-·-- --go----------------cn;-
'1 808 6 c 0 331 495 223 134 80 90 
-~------crn-a·-----()--c-----1 365 493 --·--3"·ru-----m·-------lfu----- 1o&J 
,a 808 6 c 2 3B5 506 339 120 12 104 
,4 · sue · 6 ··· c 3 319 · so-s· -- 328- r~re --- 61f · -- --··-ro-o-
,s 809 6 c 0 244 250 318 100 62 112 
~6 809 6 c 1 -2'4b- --248- - -3-9lJ -- -~-b --·- -- _71) ____ - ----11,. 
,7 809 6 c 2 279 284 423 98 70 110 
--·--,-a-·· 809 6 c 3 274 --2-n;---·410 100 78 122 
'9 810 6 c 0 264 277 293 100 62 70 
~0 '810 6 c 1 282 21JS. -- 36'5 --lu-2 -----6-2. - ---·-··"6s--
~1 810 6 c 2 276 278 413 100 58 64 
32 810 6 c · "3 ·· · 275" 21a · 413 c · · ---"96·---·s-q -----·----o-6-
~3 813 6 c 0 276 307 331 106 70 86 
~--- -cn""3-----·-6···--···--·---c-- ------ --·-- ·1-· ----ZTlr- ·-·-arr--·-··-n-s--··-··-"TTTB--·71J---- a2-
35 813 6 c 2 284 303 371 112 72 90 
~6 813 6 --- c 3 · 284 · 30!5- ·3cr6· · -1-rnr·----,u--·- -- n-
37 814 6 c 0 242 29, 243 138 80 128 
~a 814 6 c 1 2a1 --- 34·7- ·- --"2a-o---· -1,ro-----,s-- -- ·1-nr 
~9 814 6 c 2 280 344 278 134 84 116 
-·4-o ·---·· al'4·- ·-----r;-·-r--·-----.,..--~r- ----- 3"5"'1 '2'86---r!"6-·--a·b"----1zo 
41 815 6 c 0 237 325 188 130 72 11~ 
42 815 6 c 1 272 376 213 118 62 - 1"2o--
43 815 6 c 2 285 388 227 124 66 120 
44 815 6 C 3 275 359 241 T22 64 ------~22-· 
45 816 6 c 0 210 376 128 120 90 88 
-- 4-o--- -aT.:: - -··------e;----c----· 1 ·--~n-6- --rn;·-·- --2'52 rnr--6a-- '14 
47 816 6 c 2 298 406 247 116 74 96 
48 816 6 c 3 · 302 385 2a; - ·n'l2 - - ·7o· - ---· ·-v6 
49 819 6 C 0 277 363 243 122 72 tOO 
!~iO 819 .. 6 C ·1 2q5- - 379 264___ 13if ----A4--- --· -11_6_ 
~1 819 6 c 2 309 395 275 120 70 124 

































• ~--·--·• • • •• • • - - - - ·~·· '••- •' ·-- • - •-..-~ -· ~-~~ ·••r - - --·-• -- __ ..,_.. ·-· • ·-• ·--· -· 
·------------------------------------------------------------------------------------------------------------
)\/ERALL tv!EANS 52 286.307692 365.269231 295.384615 115.769231 71.3076923 101.423077 
-- - --. -
ANALYSIS OF VARI~NCE FOR VARIABLE FEV MEAtJ -- 286-.-307692- c.v. 4-;-6X~f4226-8 % 





- ---12- - --- 737~4~--0769 --6Y4-6.i73o8 ______ - ------ -----1 
--------- "3 i'S"BF.~-;1538 --- 5288 .IY5-l2Ef- - .Jo;-{) ;( 
-----36 ------ ~-341f~ ~q-b2 -- ----r,e;. f!%2--- --· 
51 -- 95959-;0-769 ---1881.5"50"53" 
F.tb (3) 3t.) = ~. ~ ~ ,c..s- ( ~ !') = .2__~ F '!_ --- ;---- --;:;I (.~ 3 C,) :; ~I 'It) 






MEAN ---3-65.269-2"3f---c.v. --- -4.284973i~-1% 
--- o"F' .. SUM 6F :c;QliA-REs ------M'E:A.K(si'JUAf~E - t":-v~-1 t~ e~ 
12 . 2~5792. 73i '19649.-3942 
3 ---- Iii-t:Hl~3e5 ---- 37oo:i.2S2- -,s.to-
---3b' .. -- - --·----aA19-~Ti5 _________ 244 :9?5"4-






Table 26 (Continued) 


















FOR VARIABLE SP 
FOR VARIABLE OP 

























MEAN 295.384615 c.v. 
sUM OF c:QUARES MEAN SQUARE F-
114{ (c e 
456013.80~ 38001.1506 




MEAN 115.769231 c.v. 4.258 
c:UM OF ~QUARES MEAN SQUARE {:._ 
vco I c.._. · 
6243.23077 520.269231 
15].07692 50.35A974 'J., D 7 
874. 9230-A 24.3031.419 
7269.23077 142.533937 
MFAN 71.3076923 c.v. 7.13 
SUM OF SQUARE~ MEAN ·s-olft;Ff[ F-Ou/14~ 
211~.07692 176.2564-10 
56.9230A 18.974359 ~.73 
931. 0"7692 .. 25.863248- -·-. "·-· -----
310;:3.07692 60.84464b 
1 of. 423077 c.v • ~ 5. a,. 
SUM OF SQUAR[S MEAN SQUARE - -- ---- ---F-
15231.6923 1269.30769 
Poil4 e 
35.9231 11.97436 ~.34 
12b3.0769 3 5 • n a 54 '7 ·~-
16530.6923 324.13122 
